Literature DB >> 23605947

Human exposure to mycotoxins in Egypt.

Am Abdalla El-Sayed1, E Aly Soher, Aa Neamat-Allah.   

Abstract

This investigation examined the exposure of Egyptian infants to Aflatoxin M1 (AfM1) and of lactating mothers to Aflatoxin B1, using AfM1 in human milk as a biomarker for exposure to AfB1. The presence of ochratoxin A (OA) in human milk was also investigated to determine the levels of infants exposure to OA from human milk. The results indicated that AfM1 was found in 66 (55 %) of 120 human milk samples with a mean of 0.3 ± 0.53 ng/mL (range 0.02 to 2.09 ng/mL). OA was found in 43 (35.8 %) of 120 human milk samples with a mean of 21.1 ± 13.7 ng/mL (range 5.07 to 45.01 ng/mL), which will cause a daily intake of OA from human milk exceeding the suggested tolerable dose of 5 ng/kg-1 of OA body weight. On the other side AfM1 was found in 25 % of blood samples (5 out of 20 samples), at a mean of 1.18 ng/mL, but it was detected only in one urine sample (1 out of 20 samples). OA was detected only in 2 out of 13 blood samples (15.4 %) with an average 3.67 ng/mL. Whereas OA was not detected in all analyzed urine samples.

Entities:  

Year:  2002        PMID: 23605947     DOI: 10.1007/BF02946136

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  23 in total

1.  Occurrence of aflatoxin M1 in commercial pasteurized milk determined with ELISA and HPLC.

Authors:  P Markaki; E Melissari
Journal:  Food Addit Contam       Date:  1997-07

2.  Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC.

Authors:  A Zarba; C P Wild; A J Hall; R Montesano; G J Hudson; J D Groopman
Journal:  Carcinogenesis       Date:  1992-05       Impact factor: 4.944

3.  Aflatoxins in breast milk, neonatal cord blood, and serum of pregnant women.

Authors:  S M Lamplugh; R G Hendrickse; F Apeagyei; D D Mwanmut
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

4.  Rapid extraction and detection of aflatoxin M1 in cow's milk by high-performance liquid chromatography and radioimmunoassay.

Authors:  G S Qian; P Yasei; G C Yang
Journal:  Anal Chem       Date:  1984-10       Impact factor: 6.986

5.  Human fetal exposure to ochratoxin A and aflatoxins.

Authors:  F E Jonsyn; S M Maxwell; R G Hendrickse
Journal:  Ann Trop Paediatr       Date:  1995

6.  Cytochrome P3-450 cDNA encodes aflatoxin B1-4-hydroxylase.

Authors:  M B Faletto; P L Koser; N Battula; G K Townsend; A E Maccubbin; H V Gelboin; H L Gurtoo
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

7.  [Determination of ochratoxin A in human milk].

Authors:  M Gareis; E Märtlbauer; J Bauer; B Gedek
Journal:  Z Lebensm Unters Forsch       Date:  1988-02

8.  Ochratoxin A in cow's milk and in human milk with corresponding human blood samples.

Authors:  A Breitholtz-Emanuelsson; M Olsen; A Oskarsson; I Palminger; K Hult
Journal:  J AOAC Int       Date:  1993 Jul-Aug       Impact factor: 1.913

9.  Evaluation of ochratoxin A level in human milk in Italy.

Authors:  C Micco; M Miraglia; C Brera; S Corneli; A Ambruzzi
Journal:  Food Addit Contam       Date:  1995 May-Jun

10.  Optimum conditions for formation of aflatoxin M1-trifluoroacetic acid derivative.

Authors:  R D Stubblefield
Journal:  J Assoc Off Anal Chem       Date:  1987 Nov-Dec
View more
  3 in total

Review 1.  The molecular epidemiology of chronic aflatoxin driven impaired child growth.

Authors:  Paul Craig Turner
Journal:  Scientifica (Cairo)       Date:  2013-12-19

2.  Prevalence of ochratoxin a in human milk in the khorrambid town, fars province, South of iran.

Authors:  Parvin Dehghan; Keyvan Pakshir; Hossein Rafiei; Mostafa Chadeganipour; Mojtaba Akbari
Journal:  Jundishapur J Microbiol       Date:  2014-07-01       Impact factor: 0.747

Review 3.  Ochratoxin A: 50 Years of Research.

Authors:  Frantisek Malir; Vladimir Ostry; Annie Pfohl-Leszkowicz; Jan Malir; Jakub Toman
Journal:  Toxins (Basel)       Date:  2016-07-04       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.